Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Research and Development Expenses

v3.10.0.1
Research and Development Expenses
12 Months Ended
Dec. 31, 2017
Research And Development Expenses  
RESEARCH AND DEVELOPMENT EXPENSES
NOTE 13:- RESEARCH AND DEVELOPMENT EXPENSES

 

     

Year ended

December 31,

 
      2017     2016     2015  
      USD  
                     
  Clinical and preclinical trials   $ 3,809     $ 5,104     $ 2,814  
  Salary and related expenses     888       664       663  
  Patents     234       198       216  
  Royalties     11       11       61  
  Laboratory materials     63       38       49  
  Rent     51       48       47  
  Depreciation     3       4       4  
  Others     47       48       50  
                           
      $ 5,106     $ 6,115     $ 3,904